Gregory Tiesi MD
Endocrine, Surgical Oncology (Other than Breast)
Medical Director of Hepatobiliary Surgery
Join to View Full Profile
19 Davis Ave2nd FloorNeptune, NJ 07753
Phone+1 732-776-4770
Dr. Tiesi is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Gregory Tiesi is the Medical Director of Hepatobiliary Surgery at the Jersey Shore University Medical Center as part of the Hackensack Meridian Healthcare System. He is a member of the Pancreatic Cancer working group within the Alliance for Clinical Trials in Oncology. He also sits on the Scientific Advisory Committee for CorriXR Therapeutics.
Education & Training
University of Miami/Jackson Health SystemFellowship, Complex General Surgical Oncology, 2014 - 2016
Rutgers Health/New Jersey Medical SchoolResidency, Surgery, 2007 - 2014
St. George's University School of MedicineClass of 2007
Certifications & Licensure
NJ State Medical License 2012 - 2027
DE State Medical License 2016 - 2025
FL State Medical License 2014 - 2016
American Board of Surgery Surgery- American Board of Surgery Complex General Surgical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification HealtheLife and PowerChart, Cerner Corporation, 2017
- CMS Meaningful Use Stage 1 Certification PowerChart (CQM), Cerner Corporation, 2017
- CMS Meaningful Use Stage 1 Certification Cerner Sentinel Cloud Auditing, Cerner Corporation, 2017
Publications & Presentations
PubMed
- Genotypic and Phenotypic Diversity as a Function of CRISPR-Directed Gene Knock-Out ofin Pancreatic Adenocarcinoma Cells, a Feasibility Study.London P McGill, Kelly H Banas, Gregory Tiesi, Eric B Kmiec
Biomolecules. 2026-06-03 - 6 citationsReview of Safety Data for Adenovirus 5 as a Delivery Vector for Intratumoral Cancer Gene Therapy.Yarrow Sheldon, Byung-Chun Yoo, Eric Kmiec, Nicholas Petrelli, Gregory Tiesi
Human Gene Therapy. 2023-04-01 - 2 citationsA cost analysis of sorafenib for desmoid tumors.Michael S Johns, William T Merritt 3rd, Lori Rhodes, Candice N Ford, Mark Thompson
Journal of Oncology Pharmacy Practice. 2023-04-01
Press Mentions
D’Angelo’s Death at 51 Highlights Pancreatic Cancer Risks in Black CommunityOctober 23rd, 2025- Jersey Shore Debuts N.J.’s First TAMP Cancer TherapyApril 17th, 2025
- Jersey Shore University Medical Center Welcomes Dr. Gregory Tiesi as Medical Director of Hepatobiliary SurgeryAugust 18th, 2022
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
